Phosphorylation State-Specific Antibodies: Applications in Investigative and Diagnostic Pathology

131Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Until recently, the investigation of protein phosphorylation was limited to biochemical studies of enzyme activities in homogenized tissues. The availability of hundreds of phosphorylation state-specific antibodies (PSSAs) now makes possible the study of protein phosphorylation in situ, and is opening many exciting opportunities in investigative and diagnostic pathology. This review illustrates the power of PSSAs, especially in immunohistochemical applications to human disease and animal models. Technical considerations, including antibody specificity and lability of phosphoepitopes, are covered, along with potential pitfalls, illustrated by a case study. In the arena of oncology, PSSAs may prove especially valuable in directly demonstrating the efficacy of chemotherapies targeted at protein kinase cascades. Novel applications of PSSAs are also beginning to reveal molecular mechanisms of inflammatory, degenerative, and toxin-induced diseases.

Cite

CITATION STYLE

APA

Mandell, J. W. (2003). Phosphorylation State-Specific Antibodies: Applications in Investigative and Diagnostic Pathology. American Journal of Pathology. American Society for Investigative Pathology Inc. https://doi.org/10.1016/S0002-9440(10)63525-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free